TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30569662

Group type: EXPERIMENTAL
Intervention: Sanhuang Xiexin decoction + basic treatment (SX group)
Number of subjects: 121

Group type: COMPARATOR
Intervention: basic treatment (control group)
Number of subjects: 121
Study: 28650204

Group type: EXPERIMENTAL
Intervention: XEN-D0501 (oral, 4 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25905795

Group type: EXPERIMENTAL
Intervention: Meningococcal B outer membrane vesicle vaccine
Number of subjects: 0
Study: 23943734

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 44
Study: 21257977

Group type: EXPERIMENTAL
Intervention: Stress management (SM) intervention
Number of subjects: 159

Group type: COMPARATOR
Intervention: Supportive attention (SA) group
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard care (SC) group
Number of subjects: 159
Study: 19767576

Group type: EXPERIMENTAL
Intervention: Tannic acid (TA) treatment (10% and 20%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tannic acid (TA) treatment
Number of subjects: 0
Study: 17679563

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxia (IH, PetO2 approximately 40 mmHg, PetcO2 clamped to 0.4 mmHg above resting values)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham hypoxia (SH, PetO2 103 mmHg without inspired CO2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Poikilocapnic hypoxia (PH, PetO2 approximately 40 mmHg; no inspired CO2)
Number of subjects: 22
Study: 15450698

Group type: EXPERIMENTAL
Intervention: Post-ER nurse follow-up (two follow-up calls from an experienced ER nurse within 1-2 days and 3-5 days after ER discharge)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Post-ER nurse follow-up
Number of subjects: 795

Group type: COMPARATOR
Intervention: Control group (no nurse follow-up)
Number of subjects: 795
Study: 15037713

Group type: EXPERIMENTAL
Intervention: 24-hour bed rest
Number of subjects: 111

Group type: COMPARATOR
Intervention: Free mobility
Number of subjects: 111
Study: 10075899

Group type: EXPERIMENTAL
Intervention: Bimanual flexion and extension movements with alternating in‐ and antiphase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bimanual movements with attention and random movements as additional variables
Number of subjects: 0

Group type: COMPARATOR
Intervention: Condition with strictly regular movement
Number of subjects: 0
Study: 7737074

Group type: EXPERIMENTAL
Intervention: Computer-generated individualized risk feedback
Number of subjects: 1317

Group type: EXPERIMENTAL
Intervention: Risk feedback plus behavioral change feedback
Number of subjects: 1317

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 1317

Group type: EXPERIMENTAL
Intervention: Individualized risk feedback
Number of subjects: 1317
Study: 1828204

Group type: EXPERIMENTAL
Intervention: Thymopentin (three times a week for three consecutive months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thymopentin (continued treatment during phase II)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (during phase II)
Number of subjects: 20
Study: 6263396

Group type: EXPERIMENTAL
Intervention: Bran crispbread
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ispaghula drink
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 31792478

Group type: EXPERIMENTAL
Intervention: Pit and fissure sealant combined with fluorine protective paint
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pit and fissure sealant
Number of subjects: 120
Study: 27843047

Group type: EXPERIMENTAL
Intervention: Metoprolol 23.75mg or 47.5mg q.d.
Number of subjects: 154
Study: 26406556

Group type: EXPERIMENTAL
Intervention: Unilateral cleft lip and palate subjects (UCLP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-cleft (nonCLP) controls
Number of subjects: 30
Study: 24814618

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deferoxamine
Number of subjects: 0
Study: 22927995

Group type: EXPERIMENTAL
Intervention: 21‐h simulated military mission (SMM) with equipment weighing ∼27 kg during battles and ∼43 kg during marches
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 21‐h simulated military mission (SMM)
Number of subjects: 10
Study: 19852289

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metformin (WM1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cyproterone (WM2)
Number of subjects: 100
Study: 17885221

Group type: EXPERIMENTAL
Intervention: Surgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Number of subjects: 0
Study: 15306665

Group type: EXPERIMENTAL
Intervention: CPR plus the use of AEDs
Number of subjects: 19000

Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 19000
Study: 11870120

Group type: EXPERIMENTAL
Intervention: K-soft 5000
Number of subjects: 1296

Group type: COMPARATOR
Intervention: TDT set
Number of subjects: 1296
Study: 9803702

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: 12-step facilitation (12SF)
Number of subjects: 128
Study: 7697378

Group type: EXPERIMENTAL
Intervention: Bulimia Nervosa (BN) patients
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Anorexia Nervosa (AN) patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 22
Study: 28902112

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 16
Study: 30222505

Group type: EXPERIMENTAL
Intervention: Breast Cancer Risk Assessment and Education (BreastCARE) intervention
Number of subjects: 1235

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1235
Study: 28035845

Group type: EXPERIMENTAL
Intervention: Superior peripheral iridotomy (LPI)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Inferior peripheral iridotomy (LPI)
Number of subjects: 164
Study: 24915135

Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 200
Study: 24092940

Group type: EXPERIMENTAL
Intervention: Neoadjuvant lapatinib
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Neoadjuvant trastuzumab
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Combination of lapatinib and trastuzumab
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT metabolic response
Number of subjects: 455

Group type: COMPARATOR
Intervention: (18)F-FDG PET/CT responders
Number of subjects: 455
Study: 20937650

Group type: EXPERIMENTAL
Intervention: Modified version of the Mother‐Infant Transaction Program
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146
Study: 17661847

Group type: EXPERIMENTAL
Intervention: HAART initiation
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: HAART interruption
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: HAART resumption
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Low baseline ferritin
Number of subjects: 138
Study: 16366764

Group type: EXPERIMENTAL
Intervention: Lorazepam (1.0, 2.0 mg/70 kg, oral)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.3, 0.6 mg/70 kg, subcutaneous)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11898005

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 570

Group type: COMPARATOR
Intervention: 0.1% hydrocortisone butyrate ointment
Number of subjects: 570
Study: 9928964

Group type: EXPERIMENTAL
Intervention: Three counseling sessions designed to reduce further abuse
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wallet-sized cards listing community resources for abuse
Number of subjects: 132
Study: 7495919

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention including biofeedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 2125252

Group type: EXPERIMENTAL
Intervention: Rheum E
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rheum E + Captopril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dietary therapy alone
Number of subjects: 30
Study: 7297433

Group type: EXPERIMENTAL
Intervention: 10 ml of magaldrate administered every two hours
Number of subjects: 9

Group type: COMPARATOR
Intervention: 15 ml of magaldrate administered every three hours
Number of subjects: 9
Study: 31050949

Group type: EXPERIMENTAL
Intervention: SRP + Laser (SRP + L)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 38
Study: 26547392

Group type: EXPERIMENTAL
Intervention: Jigsaw learning method
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lecture-based learning method
Number of subjects: 50
Study: 26018225

Group type: EXPERIMENTAL
Intervention: Cognitive-motor dual-task training (DT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Single-task training (ST)
Number of subjects: 27
Study: 23896100

Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control
Number of subjects: 176
Study: 21511709

Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during 10% MVC contraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation during relaxed condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during relaxed condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation during 5-10% MVC contraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 Hz stimulation during 10% MVC contraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation during 1-5% MVC contraction
Number of subjects: 0
Study: 19631773

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound treatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (no low-intensity pulsed ultrasound treatment)
Number of subjects: 7
Study: 17355303

Group type: EXPERIMENTAL
Intervention: Vabra aspirator
Number of subjects: 147

Group type: COMPARATOR
Intervention: Pipelle device
Number of subjects: 147
Study: 16344342

Group type: EXPERIMENTAL
Intervention: Azathioprine, up to 3 mg/kg daily, individually adjusted according to blood lymphocyte number and the occurrence of adverse events.
Number of subjects: 14
Study: 11949925

Group type: EXPERIMENTAL
Intervention: Handbook-only group received the Medicare & You 1999 handbook.
Number of subjects: 2107

Group type: EXPERIMENTAL
Intervention: Bulletin group received an abbreviated version of the handbook.
Number of subjects: 2107

Group type: EXPERIMENTAL
Intervention: Handbook + CAHPS group received the Medicare & You handbook plus the CAHPS survey report.
Number of subjects: 2107

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 2107
Study: 9585822

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ebastine tablets
Number of subjects: 110
Study: 7707108

Group type: EXPERIMENTAL
Intervention: CMFVP (1 year of therapy with continuous cyclophosphamide, methotrexate, fluorouracil (5‐FU), vincristine, and prednisone)
Number of subjects: 531

Group type: COMPARATOR
Intervention: FAC-M (20 weeks of therapy with four 5‐week courses of treatment with 5‐FU, doxorubicin, cyclophosphamide, and methotrexate)
Number of subjects: 531
Study: 2576201

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Mepindolol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Propranolol and Mepindolol
Number of subjects: 9
Study: 58143

Group type: EXPERIMENTAL
Intervention: B.C.G. plus 5-fluorouracil (5-F.U.)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: B.C.G. alone
Number of subjects: 83
Study: 31804779

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 30898175

Group type: EXPERIMENTAL
Intervention: micellised vitamin D3 (DePura)
Number of subjects: 180

Group type: COMPARATOR
Intervention: conventional vitamin D3 (Calcirol)
Number of subjects: 180
Study: 28284745

Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (ZA) for 4 years
Number of subjects: 170

Group type: COMPARATOR
Intervention: Zoledronic Acid (ZA) for 2 years (Control)
Number of subjects: 170
Study: 27088271

Group type: EXPERIMENTAL
Intervention: Kinesio taping plus paracetamol
Number of subjects: 65

Group type: COMPARATOR
Intervention: Paracetamol (control)
Number of subjects: 65
Study: 23536124

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 998

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 998
Study: 22075964

Group type: EXPERIMENTAL
Intervention: non-psychiatric, indigenous label + lay help-seeking
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: psychiatric diagnostic label + lay help-seeking
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: prior contact in the non-psychiatric, indigenous label + lay help-seeking condition
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: treated psychosis condition
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: untreated psychosis condition
Number of subjects: 160
Study: 19609048

Group type: EXPERIMENTAL
Intervention: Reopening of a totally occluded IRA (study group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Partially occluded IRA (control group)
Number of subjects: 60
Study: 17205319

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Risperidone 1 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16265986

Group type: EXPERIMENTAL
Intervention: Xiao Yao Wan containing Chai Hu
Number of subjects: 58

Group type: COMPARATOR
Intervention: Zhi Bai Di Huang Wan
Number of subjects: 58
Study: 12125505

Group type: EXPERIMENTAL
Intervention: Furosemide + albuterol (1 and 0.15 mg/kg, respectively)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Albuterol (0.15 mg/kg)
Number of subjects: 20
Study: 10638174

Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin gel
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8574256

Group type: EXPERIMENTAL
Intervention: 35 micrograms ethinyl estradiol (EE) + 250 micrograms norgestimate (Cilest)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20 micrograms EE + 150 micrograms desogestrel (Mercilon)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE + 150 micrograms desogestrel (Marvelon)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE + 75 micrograms gestodene (Femodene)
Number of subjects: 100
Study: 2136041

Group type: EXPERIMENTAL
Intervention: Tight fitting bikini type briefs
Number of subjects: 2

Group type: COMPARATOR
Intervention: Loose fitting boxer type briefs
Number of subjects: 2
Study: 537957

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 15
Study: 30027768

Group type: EXPERIMENTAL
Intervention: i.d.EP + i.m.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: i.d. + i.m.EP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: i.d.EP + i.m.EP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 100
Study: 26658119

Group type: EXPERIMENTAL
Intervention: Colostrum administration every 2 h for 46 h
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 12
Study: 24884888

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural therapy (8 modules delivered online)
Number of subjects: 0
Study: 22305246

Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20386309

Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 levels > or =220 pg/mL
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 cutoff <220 pg/mL
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐8 cutoff <220 pg/mL in adults aged <40 yrs
Number of subjects: 192
Study: 19030753

Group type: EXPERIMENTAL
Intervention: Peridural anesthesia with 0.75% ropivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Peridural anesthesia with 0.75% ropivacaine and 150 microg of clonidine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 0.5% bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 0.5% bupivacaine and 50 microg of clonidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 15974218

Group type: EXPERIMENTAL
Intervention: Bleaching gel with added amorphous calcium phosphate (ACP)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control gel
Number of subjects: 27
Study: 12675869

Group type: EXPERIMENTAL
Intervention: Serial slow-flow pressure (SFpr = OP/MABP at Qb of 50 mL/min)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: SFpr monitoring
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Threshold of OP/MABP at Qb 0 (>0.53) and SFpr (>0.6)
Number of subjects: 152
Study: 10232432

Group type: EXPERIMENTAL
Intervention: Pulmonary function tests during the acute phase of the disease (TL,COss and TL,COsb)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pulmonary function tests after a mean of 21 months
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Clinical recovery observation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Recurrences of clinical signs
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pulmonary function abnormalities
Number of subjects: 15
Study: 8908436

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin ophthalmic solution 0.3%
Number of subjects: 131

Group type: COMPARATOR
Intervention: Norfloxacin ophthalmic solution 0.3%
Number of subjects: 131
Study: 1827418

Group type: EXPERIMENTAL
Intervention: 0.020 mg ethynilestradiol + 0.150 mg desogestrel (Mercilon)
Number of subjects: 852

Group type: COMPARATOR
Intervention: 0.030 mg ethynilestradiol + 0.150 mg desogestrel (Marvelon)
Number of subjects: 852

Group type: EXPERIMENTAL
Intervention: 0.020 mg ethynilestradiol (Mercilon)
Number of subjects: 852

Group type: COMPARATOR
Intervention: 0.030 mg ethynilestradiol (Marvelon)
Number of subjects: 852

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 852
Study: 6345174

Group type: EXPERIMENTAL
Intervention: Intermittent high-dose melphalan/prednisone (MP)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Continuous low-dose melphalan (M)
Number of subjects: 219
Study: 30608426

Group type: EXPERIMENTAL
Intervention: aPDT (antimicrobial photodynamic therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scraper
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: aPDT and Scraper
Number of subjects: 0
Study: 30366229

Group type: EXPERIMENTAL
Intervention: $0 cash incentive for visiting a PCP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: $25 cash incentive for visiting a PCP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: $50 cash incentive for visiting a PCP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study: 27927248

Group type: EXPERIMENTAL
Intervention: Multipoint Pacing (MPP) using two LV pacing vectors
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard ICD
Number of subjects: 50
Study: 24502839

Group type: EXPERIMENTAL
Intervention: Functional Capacity Evaluation (FCE)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Semistructured functional interview (Control)
Number of subjects: 203
Study: 22421863

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 3
Study: 19793416

Group type: EXPERIMENTAL
Intervention: Columellar strut
Number of subjects: 93

Group type: COMPARATOR
Intervention: No columellar strut (Control)
Number of subjects: 93
Study: 17605095

Group type: EXPERIMENTAL
Intervention: AF Suppression algorithm ON (treatment group)
Number of subjects: 411

Group type: COMPARATOR
Intervention: AF Suppression algorithm OFF (control group)
Number of subjects: 411
Study: 16167247

Group type: EXPERIMENTAL
Intervention: Sigmoid coloplasty
Number of subjects: 68

Group type: COMPARATOR
Intervention: Straight sigmoidorectostomy
Number of subjects: 68
Study: 11918503

Group type: EXPERIMENTAL
Intervention: Enhanced care (EC) - clinical pharmacist collaborative care intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care (UC) - control group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Enhanced care (EC)
Number of subjects: 74
Study: 9719037

Group type: EXPERIMENTAL
Intervention: Sugar-free, urea-containing chewing gum (20 mg urea/piece), 5 pieces/day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sugar-free, non-urea-containing chewing gum, 5 pieces/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: No gum-chewing
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sugar-free, urea-containing chewing gum
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both gum periods (urea and non-urea)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All periods
Number of subjects: 29
Study: 7898342

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (N = 29)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (N = 9)
Number of subjects: 38
Study: 3190800

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms/day for 6 days
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 400 micrograms every day
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) every other day for 5 days
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) in patients with solid tumors
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) overall
Number of subjects: 102